ArticleCancers2023

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience.

Stefaan W Van Gool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.